Sonia Mangnoesing

Sonia Mangnoesing is an experienced professional in pharmacovigilance and drug safety, currently serving as the Director in Drug Safety at Arriello since January 2023. Prior roles include Principal Specialist in the QPPV Office at Syneos Health from October 2020 to January 2023, and Managing Consultant in Pharmacovigilance at ProPharma Group from February 2017 to October 2020. Sonia's background encompasses significant positions in major organizations, including Merck BV, MSD, Abbott B.V., International Flavours and Fragrances (IFF), Centocor BV, and the Medicine Evaluation Board. Sonia holds a Master’s degree in Bio-Pharmaceutical Sciences from Leiden University, obtained in 2003.